Literature DB >> 74494

Coronary heart-disease after treatment of hypertension.

G Berglund, R Sannerstedt, O Andersson, H Wedel, L Wilhelmsen, L Hansson, R Sivertsson, J Wikstrand.   

Abstract

Within a group of 1026 men aged 47-54, cause-specific death-rates and the incidence of non-fatal myocardial infarction and stroke in treatment group of 635 hypertensive men (casual systolic B.P. greater than 175 or diastolic B.P. greater than 115 mm Hg on two occasions) treated at a hypertension clinic were compared with those in a control group of 391 men (causal systolic B.P. greater than 175 or diastolic greater than 115 mm Hg on only one occasion) who remained mainly untreated during their 4.3 years of follow-up. The predicted risk of coronary heart-disease (C.H.D.) at entry, calculated by a multiple logistic function, was slightly higher in the treatment group. Total death-rate during follow-up was significantly lower in the treatment group (3.3%) than in the control group (6.1%). The difference in death-rate for C.H.D. was of the same relative order (0.8% versus 1.5%), as was the incidence of non-fatal myocardial infarction (2.8% versus 5.4%), although none of the differences reached statistical significance. However, the pooled incidence of fatal and non-fatal C.H.D. was significantly lower in the treatment group (3.6%) than in the control group (6.9%). The results suggest that antihypertensive treatment might be effective in preventing or postponing C.H.D. in middle-aged men.

Entities:  

Mesh:

Year:  1978        PMID: 74494     DOI: 10.1016/s0140-6736(78)90356-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.

Authors:  E S Dimenäs; C G Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Which drug for hypertension?

Authors: 
Journal:  Br Med J       Date:  1978-07-08

4.  Beta-blockers and plasma triglycerides.

Authors:  L Wilhelmsen
Journal:  Br Med J       Date:  1978-05-20

5.  Cost of hypertension treatment.

Authors:  T W Odell; M C Gregory
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

6.  Treatment of high blood pressure: should clinical practice be based on results of clinical trials?

Authors:  R G Wilcox; J R Mitchell; J R Hampton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

7.  Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.

Authors:  D A Burke; A T Axon
Journal:  BMJ       Date:  1988-07-09

8.  Rotavirus vaccines--achievements and prospects.

Authors:  T H Flewett
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

9.  Combination therapy in hypertension. A population-based study in eastern Finland.

Authors:  H Enlund; H Turakka; J Tuomilehto
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 10.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.